Evaluasi Penggunaan Obat Antihipertensi pada Pasien Rawat Jalan GGK dengan Hemodialisa di RSUP dr. Soeradji Tirtonegoro Klaten Tahun 2017
DOI:
https://doi.org/10.21111/pharmasipha.v3i2.3404Keywords:
antihypertensive, outpatient, CKD, hemodialysisAbstract
Hypertension is one of the major risk factors for chronic renal failure because it can cause damage to blood vessels in the kidney, thus reducing the ability of the kidneys to filter blood properly. Giving and analyzing antihypertensive drugs are very important in these circumstances, as it can accelerate the progression of the disease and increase the patient's mortality rate. Rasulullah sallallaahu 'alaihi wasallam, said: „There is a cure for every disease‟. If the medicine is right for an illness, it will be healed with the permission of Allah 'Azza wajalla "(H.R. Muslim). Therefore, the aspects of efficacy and safety of drug use in patients need to be evaluated. The purpose of this study was to determine patient accuracy, drug accuracy and dose accuracy evaluated based on reference books in the use of antihypertensive therapy in outpatients with chronic renal failure with hemodialysis. This research is a descriptive research conducted at RSUP dr. Soeradji Tirtonegoro Klaten. Data were retrospective from medical records, using non-experimental methods. The patient sample was taken according to the inclusion criteria of the research by purposive sampling method. The results of this study indicate that there were 55 patients evaluated consisted of 35 men (64%) and 20 women (36%). Based on the data obtained it can be concluded that the use of antihypertensive drugs in chronic renal failure outpatients with hemodialysis at RSUP dr. Soeradji Tirtonegoro Klaten 2017 shows right patient (100%), exact medicine (90,92%) and exact dose (98,19%).
Downloads
Published
2019-09-23
Issue
Section
Articles
License
Authors who publish with this Journal agree to the following terms:
- Author retain copyright and grant the journal right of first publication with the work simultaneously licensed under a creative commons attribution license that allow others to share the work within an acknowledgement of the work’s authorship and initial publication of this journal.
- Authors are able to enter into separate, additional contractual arrangement for the non-exclusive distribution of the journal’s published version of the work (e.g. acknowledgement of its initial publication in this journal).
- Authors are permitted and encouraged to post their work online (e.g. in institutional repositories or on their websites) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published works.
